We try to establish a standardized practices for RNA diagnostics using clinically accessible whole blood, we evaluated the two protocols (ribo-minus and the modified polyA+) by comparing the expression profiles and alternative splicing events of OMIM genes in clinical settings where RNA samples were collected primarily from patients whose whole genome data were also obtained.